Get started
Author

Mei Guan

Pembrolizumab combined with lenvatinib as non-first-line therapy in patients with refractory biliary tract carcinoma
2020 · Jianzhen Lin, Xu Yang, et al. · HepatoBiliary Surgery and Nutrition · 154
PDF
Alterations in DNA Damage Repair Genes in Primary Liver Cancer
2019 · Jianzhen Lin, Junping Shi, et al. · Clinical Cancer Research · 110
MicroRNA-1246 enhances migration and invasion through CADM1 in hepatocellular carcinoma
2014 · Zhao Sun, Changting Meng, et al. · BMC Cancer · 100
PDF
Mutational spectrum and precision oncology for biliary tract carcinoma
2021 · Jianzhen Lin, Yinghao Cao, et al. · Theranostics · 89
Adverse Events of Monoclonal Antibodies Used for Cancer Therapy
2015 · Mei Guan, Yan-Ping Zhou, et al. · BioMed Research International · 86
PDF
Real-world efficacy and prognostic factors of lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma patients
2023 · Xu Yang, Bowen Chen, et al. · Hepatology International · 63
PDF
Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma
2024 · Xu Yang, Xu Yang, et al. · BMC Medicine · 48
PDF
The Efficacy and Safety of Apatinib Plus Camrelizumab in Patients With Previously Treated Advanced Biliary Tract Cancer: A Prospective Clinical Study
2021 · Dongxu Wang, Xu Yang, et al. · Frontiers in Oncology · 48
PDF
High c-Met expression is a negative prognostic marker for colorectal cancer: a meta-analysis
2015 · HeLi Gao, Mei Guan, et al. · Tumor Biology · 40
Cell-free DNA copy number variations predict efficacy of immune checkpoint inhibitor-based therapy in hepatobiliary cancers
2021 · Xu Yang, Ying Hu, et al. · Journal for ImmunoTherapy of Cancer · 39
PDF
MicroRNA-222 influences migration and invasion through MIA3 in colorectal cancer
2017 · Heli Gao, Xuejing Cong, et al. · Cancer Cell International · 36
PDF
Role of bicyclol in preventing chemotherapeutic agent-induced liver injury in patients over 60 years of age with cancer
2014 · Xiaoyuan Li, Jianfeng Zhou, et al. · Journal of International Medical Research · 34
A single‐arm, multicenter, open‐label phase 2 trial of surufatinib in patients with unresectable or metastatic biliary tract cancer
2021 · Jianming Xu, Yuxian Bai, et al. · Cancer · 33
PDF
DNA Mismatch Repair Deficiency Detection in Colorectal Cancer by a New Microsatellite Instability Analysis System
2020 · Shafei Wu, Xiaoding Liu, et al. · Interdisciplinary Sciences Computational Life Sciences · 25
PDF
Lenvatinib Beyond First-Line Therapy in Patients With Advanced Biliary Tract Carcinoma
2022 · Yunchao Wang, Xiaobo Yang, et al. · Frontiers in Oncology · 22
PDF
Pancreatic cancer cell exosomes induce lipidomics changes in adipocytes
2022 · Shihua Wang, Meiqian Xu, et al. · Adipocyte · 21
A phase II study of neoadjuvant chemoradiotherapy with oxaliplatin and capecitabine for rectal cancer
2011 · Lin Zhao, Chunmei Bai, et al. · Cancer Letters · 20
Systemic treatment of a metastatic carotid body tumor
2020 · Jiazhang Xing, Yuejuan Cheng, et al. · Medicine · 19
Treatment of Myelodysplastic Syndrome with Cyclosporin A
2007 · Shuchang Chen, Bin Jiang, et al. · International Journal of Hematology · 18
Safety and Efficacy of PD-1/PD-L1 Inhibitors in Cancer Patients With Preexisting Autoantibodies
2022 · Hui Tang, Ruixuan Geng, et al. · Frontiers in Immunology · 14
Effects of Fertilization Patterns on the Growth of Rapeseed Seedlings and Rhizosphere Microorganisms under Flooding Stress
2024 · Xuepeng Wu, JJ Wu, et al. · Agronomy · 12
PDF
Predictive model of chemotherapy-related toxicity in elderly Chinese cancer patients
2023 · Yuwei Hua, Yuling Zou, et al. · Frontiers in Pharmacology · 10
Construction and validation of a prognostic signature using CNV-driven genes for hepatocellular carcinoma
2021 · Jin Bian, Junyu Long, et al. · Annals of Translational Medicine · 9
PDF
Combined TACE with Targeted and Immunotherapy versus TACE Alone Improves DFS in HCC with MVI: A Multicenter Propensity Score Matching Study
2025 · Xiaokun Chen, Xiangan Wu, et al. · Journal of Hepatocellular Carcinoma · 8
PDF
Efficacy of immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma and predictive potential of mutated TP53
2024 · Mingying Wu, Na Zhou, et al. · Lung Cancer · 7
Works count: 67
Citation count: 1,125
H-index: 18
I10-index: 22
Year
Topic
Type